# Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement

> **NCT05875571** · PHASE4 · RECRUITING · sponsor: **Arkansas Children's Hospital Research Institute** · enrollment: 18 (estimated)

## Conditions studied

- IUD
- Healthy Female
- Contraception
- IUD Insertion Complication

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05875571
- **Lead sponsor:** Arkansas Children's Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-05
- **Primary completion:** 2025-05
- **Final completion:** 2025-06
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05875571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05875571, "Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05875571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*